(Q38114044)

29 August 2017

0 references

Systematic meta-analysis of individual selective serotonin reuptake inhibitor medications and congenital malformations (English)

1 reference

29 August 2017

0 references

0 references

1 reference

Nicholas Myles

1

1 reference

29 August 2017

Hannah Newall

series ordinal

2

1 reference

29 August 2017

Harvey Ward

series ordinal

3

1 reference

29 August 2017

Matthew Large

series ordinal

4

1 reference

29 August 2017

language of work or name

1 reference

12 June 2013

1 reference

Australian and New Zealand Journal of Psychiatry

29 August 2017

1 reference

29 August 2017

47

1 reference

29 August 2017

11

1 reference

29 August 2017

1002-1012

1 reference

Safety of fluoxetine during the first trimester of pregnancy: a meta-analytical review of epidemiological studies.

29 August 2017

1 reference

https://api.crossref.org/works/10.1177%2F0004867413492219

Use of selective serotonin-reuptake inhibitors in pregnancy and the risk of birth defects

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867413492219

Paroxetine and congenital malformations: meta-Analysis and consideration of potential confounding factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867413492219

Prevalence of depression during pregnancy: systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867413492219

Perinatal risks of untreated depression during pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867413492219

Much ado about nothing: a comparison of the performance of meta-analytical methods with rare events.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867413492219

Pregnancy outcome of women exposed to bupropion during pregnancy: a prospective comparative study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867413492219

Relapse of major depression during pregnancy in women who maintain or discontinue antidepressant treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867413492219

Perinatal outcome following third trimester exposure to paroxetine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867413492219

Risks of congenital malformations and perinatal events among infants exposed to antidepressant medications during pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867413492219

Human neural tube defects: developmental biology, epidemiology, and genetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867413492219

Randomized trial of behavioral activation, cognitive therapy, and antidepressant medication in the acute treatment of adults with major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867413492219

A multicentre prospective controlled study to determine the safety of trazodone and nefazodone use during pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867413492219

Pregnancy outcome following gestational exposure to venlafaxine: a multicenter prospective controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867413492219

Newer antidepressants in pregnancy and rates of major malformations: a meta-analysis of prospective comparative studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867413492219

Selective serotonin reuptake inhibitor exposure during early pregnancy and the risk of birth defects

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867413492219

Effects of first-trimester fluoxetine exposure on the newborn.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867413492219

Maternal drug use in early pregnancy and infant cardiovascular defect

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867413492219

Maternal use of selective serotonin re-uptake inhibitors in early pregnancy and infant congenital malformations

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867413492219

Pregnancy outcome following maternal use of the new selective serotonin reuptake inhibitors: a prospective controlled multicenter study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867413492219

Postnatal depression: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867413492219

First-trimester use of selective serotonin-reuptake inhibitors and the risk of birth defects

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867413492219

Risks associated with selective serotonin reuptake inhibitors in pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867413492219

Selective serotonin reuptake inhibitors and risk for major congenital anomalies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867413492219

Neonatal outcome following pregnancy exposure to antidepressants: a prospective controlled cohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867413492219

Are selective serotonin reuptake inhibitors cardiac teratogens? Echocardiographic screening of newborns with persistent heart murmur

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867413492219

Does paroxetine cause cardiac malformations?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867413492219

Pregnancy outcome following first-trimester exposure to fluoxetine (Prozac)

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867413492219

Selective serotonin reuptake inhibitors in pregnancy and congenital malformations: population based cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867413492219

The epidemiology of cardiovascular defects, part I: a study based on data from three large registries of congenital malformations

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867413492219

Pregnancy outcomes following exposure to serotonin reuptake inhibitors: a meta-analysis of clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867413492219

Duration of antidepressant use during pregnancy and risk of major congenital malformations

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867413492219

Delivery outcome after maternal use of antidepressant drugs in pregnancy: an update using Swedish data

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867413492219

Infant mortality and congenital anomalies from 1950 to 1994: an international perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867413492219

Outcomes of prenatal antidepressant exposure

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867413492219

Meta-analysis of Observational Studies in Epidemiology: A Proposal for Reporting

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867413492219

Empirical assessment of effect of publication bias on meta-analyses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867413492219

Use of selective serotonin reuptake inhibitors during pregnancy and risk of major and cardiovascular malformations: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867413492219

Congenital heart disease associated with selective serotonin reuptake inhibitor use during pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867413492219

Major depression and antidepressant treatment: impact on pregnancy and neonatal outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867413492219

Maternal use of selective serotonin reuptake inhibitors and risk of congenital malformations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867413492219

First trimester paroxetine use and the prevalence of congenital, specifically cardiac, defects: a meta-analysis of epidemiological studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867413492219

21 January 2018

Identifiers

DOI

10.1177/0004867413492219

1 reference

29 August 2017

1 reference